Partners for a better quality of life
About Us
NP
Screen, Inc. is engaged in the development and marketing of its proprietary
genetic test for the screening of nasopharyngeal carcinoma (NPC). We are
committed to save lives by launching a FDA-cleared, patient-friendly screening
test for the early detection of NPC. A LTD (laboratory developed test) version
of NP Screen® assay has been commercially launched in U.S.A and Canada on a
limited basis by Primex Clinical Laboratories, Inc.
.............................................................................................................................................................................................................................
NP Screen, Inc. | 115 - 16742 Stagg Street | Van Nuys, CA
91406 | Tel: (818) 779 0510 | Fax: (818) 779 1057 | info@npscreen.com
.............................................................................................................................................................................................................................
© 2009 NP Screen, Inc. All rights reserved.